Looking Through the Imaging Perspective: the Importance of Imaging Necrosis in Glioma Diagnosis and Prognostic Prediction - Single Centre Experience

Overview

Journal Radiol Oncol

Publisher Sciendo

Specialties Oncology
Radiology

Date 2024 Feb 20

PMID 38378035

Authors

Hui Ma

Shanmei Zeng

Dingxiang Xie

Wenting Zeng

Yingqian Huang

Liwei Mazu

Nengjin Zhu

Zhiyun Yang

Jianping Chu

Jing Zhao

Affiliations

Soon will be listed here.

Abstract

Background: The aim of the study was to investigate the diagnostic value of imaging necrosis (Im) in grading, predict the genotype and prognosis of gliomas, and further assess tumor necrosis by dynamic contrast-enhanced MR perfusion imaging (DCE-MRI).

Patients And Methods: We retrospectively included 150 patients (104 males, mean age: 46 years old) pathologically proved as adult diffuse gliomas and all diagnosis was based on the 2021 WHO central nervous system (CNS) classification. The pathological necrosis (Pa) and gene mutation information were collected. All patients underwent conventional and DCE-MRI examinations and had been followed until May 31, 2021. The Im was determined by two experienced neuroradiologists. DCE-MRI derived metric maps have been post-processed, and the mean value of each metric in the tumor parenchyma, peritumoral and contralateral area were recorded.

Results: There was a strong degree of inter-observer agreement in defining Im (Kappa = 0.668, p < 0.001) and a strong degree of agreement between Im and Pa (Kappa = 0.767, p < 0.001). Compared to low-grade gliomas, high-grade gliomas had more Im (85.37%, p < 0.001), and Im significantly increased with the grade of gliomas increasing. And Im was significantly more identified in -wildtype, -non-codeletion, and -homozygous-deletion gliomas. Using multivariate Cox regression analysis, Im was an independent and unfavorable prognosis factor (Hazard Ratio = 2.113, p = 0.046) in gliomas. Additionally, extravascular extracellular volume fraction () in tumor parenchyma derived from DCE-MRI demonstrated the highest diagnostic efficiency in identifying Pa and Im with high specificity (83.3% and 91.9%, respectively).

Conclusions: Im can provide supplementary evidence beyond Pa in grading, predicting the genotype and prognosis of gliomas, and in tumor parenchyma can help to predict tumor necrosis with high specificity.

Citing Articles

Preoperative prediction of diffuse glioma type and grade in adults: a gadolinium-free MRI-based decision tree.

Azizova A, Prysiazhniuk Y, Wamelink I, Cakmak M, Kaya E, Wesseling P Eur Radiol. 2024; 35(3):1242-1254.

PMID: 39425768 PMC: 11836213. DOI: 10.1007/s00330-024-11140-5.

References

Pierallini A, Bonamini M, Pantano P, Palmeggiani F, Raguso M, Osti M . Radiological assessment of necrosis in glioblastoma: variability and prognostic value. Neuroradiology. 1998; 40(3):150-3. DOI: 10.1007/s002340050556. View

Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn J, Minniti G . Author Correction: EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2022; 19(5):357-358. PMC: 9038523. DOI: 10.1038/s41571-022-00623-3. View

Hammoud M, Sawaya R, Shi W, Thall P, Leeds N . Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neurooncol. 1996; 27(1):65-73. DOI: 10.1007/BF00146086. View

Yee P, Wei Y, Kim S, Lu T, Chih S, Lawson C . Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression. Nat Commun. 2020; 11(1):5424. PMC: 7591536. DOI: 10.1038/s41467-020-19193-y. View

Shao Y, Xiong S, Sun G, Dou W, Hu X, Yang W . Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma. Cancer Med. 2019; 9(3):959-970. PMC: 6997064. DOI: 10.1002/cam4.2775. View

Hong E, Choi S, Shin D, Jo S, Yoo R, Kang K . Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas. Korean J Radiol. 2020; 22(2):233-242. PMC: 7817637. DOI: 10.3348/kjr.2020.0011. View

Incoronato M, Grimaldi A, Mirabelli P, Cavaliere C, Parente C, Franzese M . Circulating miRNAs in Untreated Breast Cancer: An Exploratory Multimodality Morpho-Functional Study. Cancers (Basel). 2019; 11(6). PMC: 6628327. DOI: 10.3390/cancers11060876. View

Waqar M, Lewis D, Agushi E, Gittins M, Jackson A, Coope D . Cerebral and tumoral blood flow in adult gliomas: a systematic review of results from magnetic resonance imaging. Br J Radiol. 2021; 94(1125):20201450. PMC: 9327770. DOI: 10.1259/bjr.20201450. View

Hou J, Zhao R, Xia W, Chang C, You Y, Hsu J . PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis. Nat Cell Biol. 2020; 22(10):1264-1275. PMC: 7653546. DOI: 10.1038/s41556-020-0575-z. View

10.

Tao W, Zhang H, Zhang L, Gao F, Huang W, Liu Y . Combined application of pharamcokinetic DCE-MRI and IVIM-DWI could improve detection efficiency in early diagnosis of ductal carcinoma in situ. J Appl Clin Med Phys. 2019; 20(7):142-150. PMC: 6612698. DOI: 10.1002/acm2.12624. View

11.

Jiao D, Cai Z, Choksi S, Ma D, Choe M, Kwon H . Necroptosis of tumor cells leads to tumor necrosis and promotes tumor metastasis. Cell Res. 2018; 28(8):868-870. PMC: 6082890. DOI: 10.1038/s41422-018-0058-y. View

12.

Wen P, Packer R . The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications. Neuro Oncol. 2021; 23(8):1215-1217. PMC: 8328017. DOI: 10.1093/neuonc/noab120. View

13.

Wu C, Lin G, Lin Z, Zhang J, Chen L, Liu S . Peritumoral edema on magnetic resonance imaging predicts a poor clinical outcome in malignant glioma. Oncol Lett. 2016; 10(5):2769-2776. PMC: 4665258. DOI: 10.3892/ol.2015.3639. View

14.

Cha S, Tihan T, Crawford F, Fischbein N, Chang S, Bollen A . Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 2005; 26(2):266-73. PMC: 7974081. View

15.

Li Y, Qin Q, Zhang Y, Cao Y . Noninvasive Determination of the IDH Status of Gliomas Using MRI and MRI-Based Radiomics: Impact on Diagnosis and Prognosis. Curr Oncol. 2022; 29(10):6893-6907. PMC: 9600456. DOI: 10.3390/curroncol29100542. View

16.

Weller M, van den Bent M, Preusser M, Le Rhun E, Tonn J, Minniti G . EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol. 2020; 18(3):170-186. PMC: 7904519. DOI: 10.1038/s41571-020-00447-z. View

17.

Pope W, Sayre J, Perlina A, Villablanca J, Mischel P, Cloughesy T . MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol. 2005; 26(10):2466-74. PMC: 7976216. View

18.

Shen G, Wang R, Gao B, Zhang Z, Wu G, Pope W . The MRI Features and Prognosis of Gliomas Associated With IDH1 Mutation: A Single Center Study in Southwest China. Front Oncol. 2020; 10:852. PMC: 7280555. DOI: 10.3389/fonc.2020.00852. View

19.

Cosma I, Tennstedt-Schenk C, Winzler S, Nikos Psychogios M, Pfeil A, Teichgraeber U . The role of gadolinium in magnetic resonance imaging for early prostate cancer diagnosis: A diagnostic accuracy study. PLoS One. 2019; 14(12):e0227031. PMC: 6927639. DOI: 10.1371/journal.pone.0227031. View

20.

Seidel C, Dorner N, Osswald M, Wick A, Platten M, Bendszus M . Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma. BMC Cancer. 2011; 11:127. PMC: 3094323. DOI: 10.1186/1471-2407-11-127. View